Results 21 to 30 of about 2,124,017 (159)

Fusion imaging for transcatheter mitral and tricuspid interventions [PDF]

Annals of Translational Medicine, 2020
Image guidance for transcatheter mitral and tricuspid valve intervention commonly utilizes the unique advantages of both fluoroscopy and live echocardiography. In some cases, pre-procedural computed tomography is also needed. Classically, they are displayed separately even if modalities are in simultaneous use.
Pascual I, Pozzoli A, Taramasso M, Maisano F, Ho EC   +4 more
openaire   +3 more sources

Transcatheter Tricuspid Interventions: Past, Present, and Future

Methodist DeBakey Cardiovascular Journal, 2023
Tricuspid regurgitation (TR) etiologies include primary valve pathology or secondary (functional) regurgitation from increased hemodynamic pressure or volume on the right side of the heart. Patients with severe TR have a worse prognosis independent of all other variables.
Colin M. Barker, Kashish Goel
openaire   +3 more sources

Functional tricuspid regurgitation: Feasibility of transcatheter interventions [PDF]

Cleveland Clinic Journal of Medicine, 2020
Functional tricuspid regurgitation (TR) develops secondary to annular dilation and leaflet tethering as a result of right ventricular remodeling. Invasive surgery for isolated TR is rarely performed due to high inpatient mortality. Transcatheter tricuspid valve intervention is an appealing solution but is challenging as crucial structures are closely ...
Vinayak, Nagaraja, Divyanshu, Mohananey, Jose, Navia, Serge C, Harb, Rhonda, Miyasaka, Amar, Krishnaswamy, Samir, Kapadia   +6 more
openaire   +2 more sources

Multi-Modality Imaging of the Tricuspid Valve: From Tricuspid Valve Disease to Catheter-Based Interventions

Reviews in Cardiovascular Medicine, 2022
Tricuspid valve disease represents a major health problem that affects a wide proportion of heart failure patients with a significant prognostic impact.
Fabio Fazzari, Francesco Cannata, Matteo Maurina, Renato Maria Bragato, Marco Francone   +4 more
doaj   +1 more source

The Current Landscape of Transcatheter Tricuspid Valve Intervention

Journal of the Society for Cardiovascular Angiography & Interventions, 2023
Tricuspid regurgitation (TR) is common, and its prevalence increases with age. It was previously estimated that there are 1.6 million patients in the United States with moderate or worse TR, and more contemporary data suggest the age-adjusted prevalence of TR is 0.55%.
Henry Seligman, Amit N. Vora, Noah Q. Haroian, Rishi Puri, Ee Ling Heng, Robert D. Smith, Azeem Latib, Raj Makkar, Paul Sorajja, Martin B. Leon, Yousif Ahmad   +10 more
openaire   +2 more sources

Update on Transcatheter Treatment of Mitral and Tricuspid Valve Regurgitation. [PDF]

, 2023
PURPOSE OF REVIEW Mitral and tricuspid regurgitation represents a clinical challenge. They are associated with a poor prognosis, and many patients are not eligible for conventional surgery.
Boone, R.H., Muller, Olivier, Praz, F., Blanke, P., Sathananthan, J., Meier, David, Praz, Fabien, Cheung, A., Tzimas, Georgios, Webb, J.G., Boone, Robert H, Webb, John G, Akodad, Mariama, Tzimas, G., Meier, D., Wood, D.A., Blanke, Philipp, Cheung, Anson, Wood, David A, Akodad, M., Muller, O., Sathananthan, Janarthanan   +21 more
core   +1 more source

Transcatheter treatment for tricuspid valve disease. [PDF]

, 2021
Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve apparatus and is observed in only 8-10% of the patients with tricuspid valve ...
Maisano, Francesco, Praz, F., Kreidel, F., Mangieri, A., Prendergast, B.D., Muraru, Denisa, Hahn, Rebecca T, Zamorano, Jose L, Mangieri, Antonio, Zamorano, J.L., von Bardeleben, Ralph Stephan, Hausleiter, Jörg, Maisano, F., Nickenig, G., Prendergast, Bernard D, Bardeleben, R.S. von, Senni, Michele, Nickenig, Georg, Delgado, V., Praz, Fabien, Lurz, P., Senni, M., Delgado, Victoria, Hausleiter, J., Lurz, Philipp, Hahn, R.T., Kreidel, Felix, Muraru, D., Felix Kreidel, Philipp Lurz, Michele Senni, Jörg Hausleiter, Fabien Praz, Rebecca T. Hahn, Ralph Stephan von Bardeleben, Denisa Muraru, Jose L. Zamorano, Antonio Mangieri, Bernard D. Prendergast, Victoria Delgado, Francesco Maisano, Georg Nickenig   +41 more
core   +2 more sources

Transcatheter Tricuspid Valve Interventions: A Triumph for Transcatheter Procedures?

Life, 2023
Tricuspid regurgitation (TR) is a common valvular pathology, estimated to affect 1.6 million people in the United States alone. Even though guidelines recommend either medical therapy or surgical treatment for TR, the misconception of TR as a benign disease along with the high mortality rates of surgical intervention led to undertreating this disease ...
Kyriakos Dimitriadis, Nikolaos Pyrpyris, Konstantinos Aznaouridis, Panagiotis Iliakis, Aggeliki Valatsou, Panagiotis Tsioufis, Eirini Beneki, Emmanouil Mantzouranis, Konstantina Aggeli, Eleftherios Tsiamis, Konstantinos Tsioufis   +10 more
openaire   +4 more sources

Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid Regurgitation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Tricuspid regurgitation (TR) frequently develops in patients with long‐standing pulmonary hypertension, and both pathologies are associated with increased morbidity and mortality.
Vera Fortmeier, Mark Lachmann, Matthias Unterhuber, Lukas Stolz, Mohammad Kassar, Laurin Ochs, Muhammed Gerçek, Anne R. Schöber, Thomas J. Stocker, Hazem Omran, Maria I. Körber, Amelie Hesse, Kai Peter Friedrichs, Shinsuke Yuasa, Tanja K. Rudolph, Michael Joner, Roman Pfister, Stephan Baldus, Karl‐Ludwig Laugwitz, Fabien Praz, Stephan Windecker, Jörg Hausleiter, Philipp Lurz, Volker Rudolph   +23 more
doaj   +1 more source

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source